Skip to main content
. 2017 Mar 8;8(22):35558–35572. doi: 10.18632/oncotarget.16009

Figure 2. Changes in depressive-like behaviors induced by CUMS and effect of meloxicam treatment.

Figure 2

a. Changes of body weight in CUMS rats after treatment with meloxicam(1 and 3mg/kg, i.g.), sertraline(5mg/kg, i.g.). B. The effects of meloxicam(1 and 3mg/kg, i.g.), sertraline (5mg/kg, i.g.) on the sucrose preference test in CUMS-treated rats. Each value represents the mean ± SD using a one-way ANOVA with a Bonferroni correction. **P < 0.01 vs control group. #and ## P < 0.05 and < 0.01 vs CUMS group. n = 10.

HHS Vulnerability Disclosure